风险管理在静脉输注化疗药物中的应用  

Risk Management in intravenous infusion of chemotherapy

作　　者：李妙青[1] 

机构地区：[1]汕头大学医学院第一附属医院胃肠外科,广东汕头515041

出　　处：《湖南中医药大学学报》2010年第10期57-58,共2页Journal of Hunan University of Chinese Medicine

摘　　要：目的分析静脉输注化疗药物的风险隐患,提出静脉化疗风险管理的对策。方法将102例胃癌根治术后患者分为对照组(51例)和观察组(51例),对照组按常规实施化疗方案,出现化疗风险时予以对症处理;观察组实施化疗方案时建立风险管理层级和流程,规范化疗护理行为。结果两组护理缺陷、投诉情况、患者满意度及化疗期间护理风险发生情况比较,差异有统计学意义(P<0.05)。结论静脉化疗风险管理对策有助于减少及避免化疗静脉渗漏,避免护理纠纷和投诉。Objective To analyze the risks of intravenous chemotherapy and to find some useful measures in risk management.Methods A total of 102 gastric carcinoma patients,received radical surgical operation,were randomly divided into 2 groups,control group(n=51) and observation group(n=51).The control group received chemotherapy,when nursing problems appeared,it was giving conventional treatment.But it was established scientific risk management steps and processes before the observation group received chemotherapy,standardizing the nursing behaviors.Results The comparisons of nursing defects,complaints,patient satisfaction and nursing care risk during chemotherapy,were significantly different(P <0.05).Conclusion Risk management measures are helpful in reducing and preventing the leakage of intravenous chemotherapy,and avoiding nursing disputes and complaints.

关 键 词：静脉输液 化疗 风险管理 对策 

分 类 号：R2[医药卫生—中医学]